                         SEQUENCE LISTING

<110>  LumiraDx UK LImited
 
<120>  IMPROVEMENTS IN OR RELATING TO NICKING ENZYMES

<130>  776.02L

<150>  US 62/864,837
<151>  2019-06-21

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  34
<212>  DNA
<213>  synthetic oligonucleotide

<400>  1
cgactccata tggagtcgat ttccccgaat tamg                                   34


<210>  2
<211>  34
<212>  DNA
<213>  synthetic oligonucleotide

<400>  2
ggactccaca cggagtcctt tttccttgtt tamc                                   34


<210>  3
<211>  33
<212>  DNA
<213>  synthetic oligonucleotide

<400>  3
ccattccttg tttactcgta tttttaggaa tgg                                    33


<210>  4
<211>  33
<212>  DNA
<213>  synthetic oligonucleotide

<400>  4
accgcgcgca ccgagtctgt cggcagcacc gct                                    33


<210>  5
<211>  16
<212>  DNA
<213>  synthetic oligonucleotide

<400>  5
agcggtgctg ccgaca                                                       16


<210>  6
<211>  12
<212>  DNA
<213>  synthetic oligonucleotide

<400>  6
ggtgcgcgcg gt                                                           12


<210>  7
<211>  25
<212>  DNA
<213>  synthetic oligonucleotide

<400>  7
accgcgcgca ccgagtctgt cggca                                             25


<210>  8
<211>  26
<212>  DNA
<213>  synthetic oligonucleotide

<400>  8
ctgccgacag actcggtgcg cgcggt                                            26


<210>  9
<211>  36
<212>  DNA
<213>  synthetic oligonucleotide

<400>  9
cacttggcat tctattacac aatagaatgc caagtg                                 36


<210>  10
<211>  36
<212>  DNA
<213>  synthetic oligonucleotide

<400>  10
catgctgagg aatattacac aatattcctc agcatg                                 36


